Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Jan;44(1):69–72. doi: 10.1136/jcp.44.1.69

Immunoassay of P2 protein in cerebrospinal fluid in neurological disorders.

J Colover 1
PMCID: PMC497019  PMID: 1705262

Abstract

Cerebrospinal fluid samples were obtained at lumbar puncture from 53 patients with a wide variety of neurological disorders. Cerebrospinal fluid samples were tested for the presence of P2 protein, a constituent of myelin, with an enzyme linked immunosorbent assay technique using a specific polyclonal antibody. High concentrations of P2 in the cerebrospinal fluid paralleled a raised IgG index (clearance ratio), the presence of oligoclonal bands, as well as raised white cell counts or depressed albumin:IgG ratios. Twenty one patients had been diagnosed as having definite or probable multiple sclerosis and the remaining 32 had other conditions. Of the 13 patients with high positive P2, 12 (92%) were in the multiple sclerosis category; of the 40 patients with low (12) or undetectable (28) P2 concentrations, only nine (23%) were diagnosed as having multiple sclerosis. In this patient population the presence of high immunoreactive P2 concentrations in cerebrospinal fluid was closely associated with evidence of intrathecal immunoglobulin synthesis and with the clinical diagnosis of multiple sclerosis. On this basis it is suggested that immunoassay of P2 concentration in the cerebrospinal fluid may be of potential value in the investigation of patients with demyelinating disorders.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colover J. A new pattern of spinal-cord demyelination in guinea pigs with acute experimental allergic encephalomyelitis mimicking multiple sclerosis. Br J Exp Pathol. 1980 Aug;61(4):390–400. [PMC free article] [PubMed] [Google Scholar]
  2. Deibler G. E., Driscoll B. F., Kies M. W. Immunochemical and biochemical studies demonstrating the identity of a bovine spinal cord protein (SCP) and a basic protein of bovine peripheral myelin (BF). J Neurochem. 1978 Feb;30(2):401–412. doi: 10.1111/j.1471-4159.1978.tb06544.x. [DOI] [PubMed] [Google Scholar]
  3. MacPherson C. F., Armstrong H., Tan O. Further characterization of the anti-encephalitogenic protein (SCP): isolation from bovine spinal cord and spinal roots. J Immunol. 1976 Jan;116(1):227–231. [PubMed] [Google Scholar]
  4. Narayanan V., Barbosa E., Reed R., Tennekoon G. Characterization of a cloned cDNA encoding rabbit myelin P2 protein. J Biol Chem. 1988 Jun 15;263(17):8332–8337. [PubMed] [Google Scholar]
  5. Thomas P. K., Walker R. W., Rudge P., Morgan-Hughes J. A., King R. H., Jacobs J. M., Mills K. R., Ormerod I. E., Murray N. M., McDonald W. I. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 1987 Feb;110(Pt 1):53–76. doi: 10.1093/brain/110.1.53. [DOI] [PubMed] [Google Scholar]
  6. Trapp B. D., Itoyama Y., MacIntosh T. D., Quarles R. H. P2 protein in oligodendrocytes and myelin of the rabbit central nervous system. J Neurochem. 1983 Jan;40(1):47–54. doi: 10.1111/j.1471-4159.1983.tb12651.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES